Mass Spectrometry Analyses of Multicellular Tumor Spheroids

Proteomics Clin Appl. 2018 May;12(3):e1700124. doi: 10.1002/prca.201700124. Epub 2018 Feb 9.

Abstract

Multicellular tumor spheroids (MCTS) are a powerful biological in vitro model, which closely mimics the 3D structure of primary avascularized tumors. Mass spectrometry (MS) has established itself as a powerful analytical tool, not only to better understand and describe the complex structure of MCTS, but also to monitor their response to cancer therapeutics. The first part of this review focuses on traditional mass spectrometry approaches with an emphasis on elucidating the molecular characteristics of these structures. Then the mass spectrometry imaging (MSI) approaches used to obtain spatially defined information from MCTS is described. Finally the analysis of primary spheroids, such as those present in ovarian cancer, and the great potential that mass spectrometry analysis of these structures has for improved understanding of cancer progression and for personalized in vitro therapeutic testing is discussed.

Keywords: cancer; drug resistance; mass spectrometry-LC-MS/MS; mass spectrometry-MALDI-TOF; multicellular tumor spheroids; ovarian cancer.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Humans
  • Mass Spectrometry / methods*
  • Neoplasms / blood supply
  • Neoplasms / pathology*
  • Spheroids, Cellular / pathology*